ImmuCell Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for ImmuCell.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Biotechs winstgroei | 27.1% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
Revenues Working Against ImmuCell Corporation's (NASDAQ:ICCC) Share Price
Aug 07
ImmuCell (NASDAQ:ICCC) Is Making Moderate Use Of Debt
Aug 10Insufficient Growth At ImmuCell Corporation (NASDAQ:ICCC) Hampers Share Price
May 27ImmuCell GAAP EPS of -$0.09, revenue of $3.86M
Aug 11ImmuCell announces preliminary 2Q sales of $3.9M
Jul 07Health Check: How Prudently Does ImmuCell (NASDAQ:ICCC) Use Debt?
Sep 15Why We Think Shareholders May Be Considering Bumping Up ImmuCell Corporation's (NASDAQ:ICCC) CEO Compensation
Jun 10Is ImmuCell (NASDAQ:ICCC) Using Too Much Debt?
Mar 15Does ImmuCell's (NASDAQ:ICCC) Share Price Gain of 38% Match Its Business Performance?
Jan 22ImmuCell reports FY20 preliminary sales
Jan 07ImmuCell restructures its bank debt
Dec 15ImmuCell EPS beats by $0.04, beats on revenue
Nov 12In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat ImmuCell onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2024 | 23 | -4 | -1 | 0 | N/A |
| 3/31/2024 | 21 | -4 | -3 | -1 | N/A |
| 12/31/2023 | 17 | -6 | -7 | -5 | N/A |
| 9/30/2023 | 16 | -6 | -9 | -5 | N/A |
| 6/30/2023 | 16 | -6 | -10 | -6 | N/A |
| 3/31/2023 | 16 | -5 | -9 | -5 | N/A |
| 12/31/2022 | 19 | -2 | -6 | -2 | N/A |
| 9/30/2022 | 20 | -1 | -3 | 0 | N/A |
| 6/30/2022 | 20 | 0 | -1 | 2 | N/A |
| 3/31/2022 | 21 | 1 | -1 | 2 | N/A |
| 12/31/2021 | 19 | 0 | -2 | 1 | N/A |
| 9/30/2021 | 18 | 0 | -2 | 1 | N/A |
| 6/30/2021 | 16 | 0 | -3 | 0 | N/A |
| 3/31/2021 | 15 | -1 | -3 | 0 | N/A |
| 12/31/2020 | 15 | -1 | -3 | 1 | N/A |
| 9/30/2020 | 15 | -2 | -3 | 1 | N/A |
| 6/30/2020 | 14 | -2 | -2 | 2 | N/A |
| 3/31/2020 | 14 | -2 | -2 | 0 | N/A |
| 12/31/2019 | 14 | -1 | -1 | 0 | N/A |
| 9/30/2019 | 13 | -2 | -1 | 0 | N/A |
| 6/30/2019 | 12 | -2 | -1 | 0 | N/A |
| 3/31/2019 | 13 | -2 | -1 | 0 | N/A |
| 12/31/2018 | 11 | -2 | -2 | 0 | N/A |
| 9/30/2018 | 11 | -1 | -7 | 0 | N/A |
| 6/30/2018 | 11 | -2 | -11 | 0 | N/A |
| 3/31/2018 | 10 | -1 | N/A | 0 | N/A |
| 12/31/2017 | 10 | 0 | N/A | 1 | N/A |
| 9/30/2017 | 10 | 0 | N/A | 0 | N/A |
| 6/30/2017 | 9 | 0 | N/A | 1 | N/A |
| 3/31/2017 | 10 | 1 | N/A | 1 | N/A |
| 12/31/2016 | 10 | 1 | N/A | 0 | N/A |
| 9/30/2016 | 10 | 1 | N/A | 1 | N/A |
| 6/30/2016 | 11 | 1 | N/A | 2 | N/A |
| 3/31/2016 | 10 | 1 | N/A | 1 | N/A |
| 12/31/2015 | 10 | 1 | N/A | 3 | N/A |
| 9/30/2015 | 10 | 1 | N/A | 2 | N/A |
| 6/30/2015 | 9 | 1 | N/A | 1 | N/A |
| 3/31/2015 | 9 | 0 | N/A | 1 | N/A |
| 12/31/2014 | 8 | 0 | N/A | 0 | N/A |
| 9/30/2014 | 7 | 0 | N/A | 0 | N/A |
| 6/30/2014 | 6 | 0 | N/A | 0 | N/A |
| 3/31/2014 | 6 | 0 | N/A | 1 | N/A |
| 12/31/2013 | 6 | 0 | N/A | 1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if ICCC's forecast earnings growth is above the savings rate (2.5%).
Winst versus markt: Insufficient data to determine if ICCC's earnings are forecast to grow faster than the US market
Hoge groeiwinsten: Insufficient data to determine if ICCC's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if ICCC's revenue is forecast to grow faster than the US market.
Hoge groei-inkomsten: Insufficient data to determine if ICCC's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if ICCC's Return on Equity is forecast to be high in 3 years time